Literature DB >> 19238877

[Folic acid and congenital malformation: scientific evidence and public health strategies].

P Salerno1, F Bianchi, A Pierini, F Baldi, P Carbone, A Mantovani, D Taruscio.   

Abstract

In Italy at least 3% of babies are born with some congenital malformation. The intake of folic acid (FA) prior to conception and during the early stages of pregnancy plays an important role in preventing neural tube defects, severe anomalies of brain embryogenesis, and other malformations such as cardiac and urinary tract anomalies, oro-facial clefts and limb reduction defects. The Italian Network for Folic Acid Promotion, coordinated by the National Center on Rare Diseases of the Italian National Institute of Health, has elaborated and diffused a recommendation for the periconceptional FA supplementation: "Women of child-bearing age, are recommended to consume 0,4 mg/day of FA, to reduce the risk of congenital defects. The intake of folic acid should start at least one month before the conception and should continue for the first quarter of pregnancy". This paper discusses various strategies in order to promote FA intake during periconceptional period. Food fortification, adopted in several countries such as USA, has raised concerns about the risk of an excessive FA intake which may lead to adverse effect such as tumour promotion. Currently, periconceptional supplementation and healthy dietary habits promotion appear to be the most effective strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19238877

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  5 in total

Review 1.  The Italian National Centre for Rare Diseases: where research and public health translate into action.

Authors:  Domenica Taruscio; Linda Agresta; Annalisa Amato; Giuseppe Bernardo; Luana Bernardo; Francesca Braguti; Pietro Carbone; Claudio Carta; Marina Ceccarini; Federica Censi; Simona Coppola; Patrizia Crialese; Marta De Santis; Stefano Diemoz; Carlo Donati; Sabina Gainotti; Gianluca Ferrari; Giovanna Floridia; Claudio Frank; Rosa Giuseppa Frazzica; Amalia E Gentile; Orietta Granata; Yllka Kodra; Manuela Latrofa; Paola Laricchiuta; Armando Magrelli; Cristina Morciano; Agata Polizzi; Stefania Razeto; Marco Salvatore; Antonella Sanseverino; Daniele Savini; Paola Torreri; Fabrizio Tosto; Flavia Villani; Giorgio Vincenti; Luciano Vittozzi
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

2.  Modelling the impact of mandatory folic acid fortification of bread or flour in Ireland on the risk of occurrence of NTD-affected pregnancies in women of childbearing age and on risk of masking vitamin B12 deficiency in older adults.

Authors:  Laura Kehoe; Janette Walton; Sinead M Hopkins; Breige A McNulty; Anne P Nugent; Albert Flynn
Journal:  Eur J Nutr       Date:  2019-10-23       Impact factor: 5.614

3.  Prevalence and determinants of preconception folic acid use: an Italian multicenter survey.

Authors:  Roy M Nilsen; Emanuele Leoncini; Paolo Gastaldi; Valentina Allegri; Rocco Agostino; Francesca Faravelli; Federica Ferrazzoli; Enrico Finale; Paolo Ghirri; Gioacchino Scarano; Pierpaolo Mastroiacovo
Journal:  Ital J Pediatr       Date:  2016-07-13       Impact factor: 2.638

4.  Women participating in a web-based preconception study have a high prevalence of risk factors for adverse pregnancy outcomes.

Authors:  Elisabetta Pandolfi; Eleonora Agricola; Micaela Veronica Gonfiantini; Francesco Gesualdo; Mariateresa Romano; Emanuela Carloni; Pierpaolo Mastroiacovo; Alberto E Tozzi
Journal:  BMC Pregnancy Childbirth       Date:  2014-05-17       Impact factor: 3.007

5.  The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.

Authors:  Xiaoyi Huang; Yisha Gao; Jing He; Jiao Cai; Na Ta; Hui Jiang; Jinhong Zhu; Jianming Zheng
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.